Versartis Inc

Versartis inc email format

Verified email-pattern data for Versartis Inc is currently limited. You can still use the company insights and contact sections below.
Versartis, Inc. is an endocrine-focused biopharmaceutical company. The Company is engaged in developing a long-acting form of recombinant human growth hormone, somavaratan (VRS-317), for growth hormone deficiency (GHD), an orphan disease. The Company's first indication for somavaratan is pediatric GHD. The Company may develop somavaratan for additional growth disorders, such as idiopathic short stature (ISS), small for gestational age (SGA) and Turner Syndrome. Somavaratan is engineered using XTEN technology to extend the residence time in the bloodstream by reducing the clearance of recombinant human growth hormone (rhGH) from the body by the two primary mechanisms, kidney filtration and receptor mediated clearance.

Company Details

Employees
9
Founded
-
Address
Menlo Park, California
Industry
Pharmaceutical Manufacturing
HQ
Menlo Park, California
Looking for a particular Versartis Inc employee's phone or email?

Versartis Inc Questions

Explore related pages

Related company profiles:

Top Versartis Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant